{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T12:11:49Z","timestamp":1761999109410,"version":"build-2065373602"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T00:00:00Z","timestamp":1679961600000},"content-version":"vor","delay-in-days":86,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IDCases"],"published-print":{"date-parts":[[2023]]},"DOI":"10.1016\/j.idcr.2023.e01753","type":"journal-article","created":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T12:34:26Z","timestamp":1680093266000},"page":"e01753","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["A difficult to treat Leishmania infantum relapse after allogeneic stem cell transplantation"],"prefix":"10.1016","volume":"32","author":[{"given":"Rob J.W.","family":"Arts","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Genevi\u00e8ve I.C.G.","family":"Ector","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pau","family":"Bosch-Nicolau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isreal","family":"Molina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew B.B.","family":"McCall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter J.F.M.","family":"van der Velden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6607-4075","authenticated-orcid":false,"given":"Arjan","family":"van Laarhoven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quirijn","family":"de Mast","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9742-674X","authenticated-orcid":false,"given":"Suzanne","family":"van Dorp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.idcr.2023.e01753_bib1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0010745","article-title":"Leishmaniasis epidemiology in endemic areas of metropolitan France and its overseas territories from 1998 to 2020","volume":"16","author":"Pasquier","year":"2022","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.idcr.2023.e01753_bib2","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(18)31204-2","article-title":"Leishmaniasis","volume":"392","author":"Burza","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.idcr.2023.e01753_bib3","unstructured":"WHO guideline for the treatment of visceral leishmaniasis in HIV co-infected patients in East Africa and South-East Asia; 2022."},{"key":"10.1016\/j.idcr.2023.e01753_bib4","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.jiac.2018.05.008","article-title":"Visceral leishmaniasis in hematopoietic cell transplantation: case report and review of the literature","volume":"24","author":"Tatarelli","year":"2018","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.idcr.2023.e01753_bib5","first-page":"31","article-title":"Leishmaniasis in solid organ and hematopoietic stem cell transplant recipients","author":"Gajurel","year":"2017","journal-title":"Clin Transpl"},{"key":"10.1016\/j.idcr.2023.e01753_bib6","doi-asserted-by":"crossref","first-page":"e202","DOI":"10.1093\/cid\/ciw670","article-title":"Diagnosis and treatment of leishmaniasis: clinical practice guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH)","volume":"63","author":"Aronson","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idcr.2023.e01753_bib7","unstructured":"Gradoni L, L\u00f3pez-V\u00e9lez R, Mokni M. Manual on case management and surveillance of the leishmaniases in the WHO European Region; 2017."},{"key":"10.1016\/j.idcr.2023.e01753_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006052","article-title":"Drug resistance and treatment failure in leishmaniasis: a 21st century challenge","volume":"11","author":"Ponte-Sucre","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.idcr.2023.e01753_bib9","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.24599","article-title":"Global distribution of treatment resistance gene markers for leishmaniasis","volume":"36","author":"Salari","year":"2022","journal-title":"J Clin Lab Anal"},{"key":"10.1016\/j.idcr.2023.e01753_bib10","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1086\/595710","article-title":"Parasite susceptibility to amphotericin B in failures of treatment for visceral leishmaniasis in patients coinfected with HIV type 1 and Leishmania infantum","volume":"48","author":"Lachaud","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idcr.2023.e01753_bib11","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1128\/AAC.00030-11","article-title":"Mechanism of amphotericin B resistance in clinical isolates of Leishmania donovani","volume":"56","author":"Purkait","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.idcr.2023.e01753_bib12","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1159\/000337341","article-title":"Development of splenic marginal zone lymphoma in a HIV-negative patient with visceral leishmaniasis","volume":"128","author":"Vase","year":"2012","journal-title":"Acta Haematol"},{"key":"10.1016\/j.idcr.2023.e01753_bib13","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1111\/j.1468-1293.2010.00846.x","article-title":"'Active chronic visceral leishmaniasis' in HIV-1-infected patients demonstrated by biological and clinical long-term follow-up of 10 patients","volume":"11","author":"Bourgeois","year":"2010","journal-title":"HIV Med"},{"key":"10.1016\/j.idcr.2023.e01753_bib14","doi-asserted-by":"crossref","first-page":"ofy323","DOI":"10.1093\/ofid\/ofy323","article-title":"Double infection with","volume":"5","author":"Al Balushi","year":"2018","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.idcr.2023.e01753_bib15","doi-asserted-by":"crossref","first-page":"789","DOI":"10.4269\/ajtmh.18-0949","article-title":"Natural resistance of","volume":"101","author":"Carnielli","year":"2019","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.idcr.2023.e01753_bib16","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ebiom.2018.09.029","article-title":"A Leishmania infantum genetic marker associated with miltefosine treatment failure for visceral leishmaniasis","volume":"36","author":"Carnielli","year":"2018","journal-title":"eBioMedicine"},{"key":"10.1016\/j.idcr.2023.e01753_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006988","article-title":"A randomized trial of AmBisome monotherapy and AmBisome and miltefosine combination to treat visceral leishmaniasis in HIV co-infected patients in Ethiopia","volume":"13","author":"Diro","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.idcr.2023.e01753_bib18","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1093\/cid\/ciac127","article-title":"AmBisome monotherapy and combination AmBisome-miltefosine therapy for the treatment of visceral leishmaniasis in patients coinfected with human immunodeficiency virus in India: a randomized open-label, parallel-arm, phase 3 trial","volume":"75","author":"Burza","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idcr.2023.e01753_bib19","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1093\/jac\/dks275","article-title":"Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis","volume":"67","author":"Dorlo","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.idcr.2023.e01753_bib20","doi-asserted-by":"crossref","first-page":"767","DOI":"10.4269\/ajtmh.14-0721","article-title":"Inadequacy of 12-week miltefosine treatment for Indian post-kala-azar dermal leishmaniasis","volume":"93","author":"Ghosh","year":"2015","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.idcr.2023.e01753_bib21","doi-asserted-by":"crossref","first-page":"424","DOI":"10.3389\/fcimb.2019.00424","article-title":"How to B(e)-1 important cell during","volume":"9","author":"Firmino-Cruz","year":"2019","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.idcr.2023.e01753_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.108969","article-title":"Immunotherapy for visceral leishmaniasis: a trapeze of balancing counteractive forces","volume":"110","author":"Mazire","year":"2022","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.idcr.2023.e01753_bib23","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1056\/NEJM199001043220104","article-title":"Treatment of visceral leishmaniasis with pentavalent antimony and interferon gamma","volume":"322","author":"Badaro","year":"1990","journal-title":"N Engl J Med"}],"container-title":["IDCases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221425092300077X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221425092300077X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T12:06:56Z","timestamp":1761998816000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221425092300077X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":23,"alternative-id":["S221425092300077X"],"URL":"https:\/\/doi.org\/10.1016\/j.idcr.2023.e01753","relation":{},"ISSN":["2214-2509"],"issn-type":[{"type":"print","value":"2214-2509"}],"subject":[],"published":{"date-parts":[[2023]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A difficult to treat Leishmania infantum relapse after allogeneic stem cell transplantation","name":"articletitle","label":"Article Title"},{"value":"IDCases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idcr.2023.e01753","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e01753"}}